Catenae Innovation PLC (AIM: CTEA), the AIM-quoted provider of digital media and technology, announces that it has responded to the Government’s call for evidence on whether COVID-status certification could play
Futura Medical PLC (FUM.L) US FDA Agreement for Confirmatory Clinical study
Futura Medical Receives US FDA Agreement for Confirmatory Clinical study, FM71 for MED3000
Futura Medical PLC (FUM.L) Futura Announces Investment & Joint Collaboration
Futura Medical Announces Investment and Joint Collaboration to Commercialise MED3000 in China and South East Asia
Guy Meyer, CEO of Catenae Innovation (CTEA.L) Interview
Catenae Innovation PLC (AIM: CTEA), the AIM-quoted provider of digital media and technology, announced that it has been invited by the UK Government’s Department for Digital, Culture, Media and Sport
Catenae Innov. PLC (CTEA.L) Digital Identity Policy Consultation
Catenae participates in consultation of UK Government’s ‘Digital Identity Policy’
Rob Naylor, incoming CEO Intuitive Investments Group (IIG.L) Interview
The Company is a newly established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast-growing and/or high potential Life Sciences businesses operating predominantly in the
Dr Hugo Stephenson, CEO of Induction Healthcare Group PLC (INHC.L) Interview
Dr Hugo Stephenson, Joint-CEO of Induction Healthcare, said: The Group has generated excellent commercial momentum in the first half of the current financial year and has delivered its first full
TPI provides its latest research note on Intuitive Investments Group (IIG.L).
IIG has today been Admitted onto London’s AIM. IIG is an investment group that seeks to leverage the expertise and extensive networks of its Board and Advisory Panel in the
Immunodiagnostic Sys (IDH.L) Launch of SARS-CoV-2 Antigen Rapid Tests
Immunodiagnostic Systems Holdings plc (IDS), a specialty solution provider to the clinical laboratory diagnostic market, announces that two SARS-CoV-2 Antigen Rapid Test kits are now available for sale in the
TPI provides its latest research note on Scancell Holdings plc (SCLP.L).
The transformative phase of capital raising that Scancell has undertaken to date in 2020 now appears to have drawn to a close.
Q-AI Limited (IQAI.L) IB and the Mayo Clinic enter into an Agreement
IB and the Mayo Clinic Enter into an Agreement to Develop IB Trax™
IQ-AI Limited (IQAI.L) Montgomery Cancer Center Purchases IB’s Software
Imaging Biometrics®, LLC (“IB”), a subsidiary of IQ-AI Limited (LON:IQAI), is pleased to announce that the Montgomery Cancer Center (Montgomery, Alabama, USA), has purchased IB Clinic.